GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis
Today GE HealthCare (Nasdaq: GEHC) announced an industry-first US FDA 510K clearance of Critical Care Suite 2.1 featuring a Pneumothorax (PTX) algorithm for the detection, notification, triage and diagnosis of PTX.
- Today GE HealthCare (Nasdaq: GEHC) announced an industry-first US FDA 510K clearance of Critical Care Suite 2.1 featuring a Pneumothorax (PTX) algorithm for the detection, notification, triage and diagnosis of PTX.
- View the full release here: https://www.businesswire.com/news/home/20231128224829/en/
On-device, CCS2.1 output from GE HealthCare's AMX Navigate mobile X-ray system showing PTX overlay and confidence level. - With this latest update, Critical Care Suite 2.1 provides immediate on-device detection and triage notifications for the presence or absence of pneumothorax (PTX).
- By hosting Critical Care Suite on-device, critical insights are available at the point of care and across the entire clinical care team.